Clinical Trial Update: Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating the efficacy and safety of tocilizumab for treating acute chest syndrome in patients with sickle cell disease. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sickle Cell Disease, Acute Chest Syndrome | Phase 3 | Status: NOT_YET_RECRUITING